Figure 5From: Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial Subjects reporting no abdominal pain on Day 36 and 66. RP-G28 (n = 36), Placebo (n = 19), p = 0.0190.Back to article page